Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Hong Kong
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Supply Chain

China Renji Medical Group Ltd/Hong Kong

+ Add to Watchlist

648:HK

0.220 HKD 0.011 4.76%

As of 03:01:04 ET on 01/28/2015.

Snapshot for China Renji Medical Group Ltd/Hong Kong (648)

Open: 0.233 Day's Range: 0.217 - 0.234 Volume: 19,798,492
Previous Close: 0.231 52wk Range: 0.217 - 1.096 1-Yr Rtn: -61.07%

Stock Chart for 648

No chart data available.
  • 648:HK 0.220
  • 1D
  • 1M
  • 1Y
0.231
Interactive 648 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 648

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. HSI -
Earnings Per Share (ttm) -0.0015
Est. EPS -
Est. PEG Ratio -
Market Cap (M HKD) 245.77
Shares Outstanding (M) 1,117.13
30 Day Average Volume 24,906,440
Price/Book (mrq) 0.4231
Price/Sale (ttm) 1.6406
Dividend Indicated Gross Yield -%
Cash Dividend (HKD) -
Dividend Ex-Date 12/12/1995
5 Year Dividend Growth -
Next Earnings Announcement 03/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 648

  • Revenue
  • Net Income (M/HKD)
  • Profit Margin (%)

Company Profile & Key Executives for 648

China Renji Medical Group Limited, through its subsidiaries, manages and operates a network of medical centers specializing in the diagnosis and treatment of tumors and cancer in China.

Hui Ka ChunExecutive DirectorWang JianguoExecutive Director
Chan Ka ChungExecutive DirectorCheung Wei KwanExecutive Director
More Company Profile & Key Executives for 648

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil